Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

News Centre

  • Pioneering Biotech Company BioVersys Opens IPO Season At SIX Swiss Exchange

    Date 07/02/2025

    Today, BioVersys (Ticker “BIOV”), a leading Swiss biotech company specializing in novel antibacterial products for serious life-threatening infections, listed its shares at SIX Swiss Exchange. At an opening price of CHF 36.50 per share, the resulting market capitalization of BioVersys was around CHF 216 million.

  • Nasdaq Stockholm Welcomes Asmodee To The Main Market

    Date 07/02/2025

    Nasdaq (Nasdaq: NDAQ) announces that trading in the B-shares of Asmodee Group AB (ticker name: ASMDEE B) will commence today on the Nasdaq Stockholm Main Market. Asmodee is a large-cap company within the Consumer Discretionary sector. Asmodee is the 5th company to be admitted to trading on Nasdaq’s Nordic and Baltic markets* in 2025.

  • Join ETFGI In Celebrating 35 Years Of ETFs In Canada At The ETFGI Global ETFs Insights Summit In Toronto On December 9th!

    Date 07/02/2025

    ETFGI is excited to announce that its 7th Annual ETFGI Global ETFs Insights Summit - Canada will take place in Toronto at Borden Ladner Gervais LLP (BLG)’s office on December 9th!

  • Hex Trust Secures Strategic Investment From Morgan Creek

    Date 07/02/2025

    Hex Trust, a leading digital assets financial service provider specializing in custody, staking, and market services, has successfully secured a strategic funding round led by Morgan Creek Digital with participation from global investors including Injective. Hex Trust's total funding to date is over $100 million. This latest investment marks a pivotal milestone as Hex Trust prepares for its Series C raise anticipated for later in 2025.

  • Correction To ASX Group Monthly Activity Report - January 2025

    Date 07/02/2025

    Trading – Cash Markets (including equities, interest rate and ETP trades)

    • In January 2025, the average daily number of trades was up 15% on the pcp. The average daily value traded onmarket of $4.571 billion was up 3% on the pcp. 
    • Volatility (as measured by the average daily movement in the All Ordinaries Index) was 0.5% in January, compared to 0.5% in the pcp. 
    • Future volatility (as measured by the S&P/ASX 200 VIX) in January was an average of 10.9, down 2% on pcp.